1. Pharmacokinetics and safety of an 8 week continuous treatment with once-daily versus twice-daily inhalation of tobramycin in cystic fibrosis patients. (30th November 2015) Authors: van Koningsbruggen-Rietschel, S.; Heuer, H. E.; Merkel, N.; Posselt, H. G.; Staab, D.; Sieder, C.; Ziegler, J.; Krippner, F.; Rietschel, E. Journal: Journal of antimicrobial chemotherapy Issue: Volume 71:Number 3(2016:Mar.) Page Start: 711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗